Study Summary
The study is an early, open, single-centered trial.
Interested in this trial?
Submit an InquiryInterventions
GC007FBIOLOGICAL
GC007F is the CAR-T cell immunotherapy targeted CD19. The subjects will receive GC007F as one dose. The dosage ranges from 6×10\^4 to 2×10\^6 CAR+T/Kg.
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Hebei Yanda Ludaopei Hospital | Sanhe | Hebei | China |